Risk of Guillain-Barre Syndrome and H1N1 Influenza Vaccination

J Gordon Millichap

doi:10.15844/pedneurbriefs-26-8-10

Risk of Guillain-Barre Syndrome and H1N1 Influenza Vaccination

Pediatric Neurology Briefs

Volume 26 (2012): Issue 8

By: J Gordon Millichap

Open Access

|Aug 2012

Abstract

Researchers at Laval University, Department of Pediatric Neurology (Dr Boucher), Quebec University Hospital and other centers in Montreal, Quebec, Canada assessed the risk of Guillain-Barre syndrome (GBS) following the pandemic influenza vaccination campaign in 2009, mostly using an AS03 adjuvant vaccine.

References

De Wals P Deceuninck G Toth E Boulianne N Brunet D Boucher RM Risk of Guillain-Barre syndrome following H1N1 influenza vaccination in Quebec JAMA 2012 Jul 11 308 2 175 81 10.1001/jama.2012.7342 22782419
Open DOI Search in Google Scholar Back to article
Tokars JI Lewis P DeStefano F Wise M Viray M Morgan O The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses Pharmacoepidemiol Drug Saf 2012 May 21 5 546 52 10.1002/pds.3220 22407672
Open DOI Search in Google Scholar Back to article
Kelly H Carcione D Dowse GK Effler P The vaccine-attributable risk for febrile convulsions following influenza vaccine Pediatr Infect Dis J 2012 Jul 31 7 792 10.1097/INF.0b013e31825686d0 22695195
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-26-8-10 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 63 - 64

Published on: Aug 1, 2012

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Guillain-Barre Syndrome,

Influenza A (H1N1) Vaccination,

Fluvax

© 2012 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 26 (2012): Issue 8